Agents2h ago
Katalyze AI Raises $10.5M For Pharma Agents
A $10.5 million seed round fuels Katalyze AI as it targets pharmaceutical manufacturing. The San Francisco startup builds agentic workflows to unify fragmented data systems used by scientists. This move shifts AI focus from drug discovery to the operational side of life sciences. Practitioners can expect faster data synthesis during critical production decisions.